Boyer CM - Search Results

1

Immunohistochemical expression of CA 125 in endometrial adenocarcinoma: correlation of antigen expression with metastatic potential.

Berchuck A, Soisson AP, Clarke-Pearson DL, Soper JT, Boyer CM, Kinney RB, McCarty KS Jr, Bast RC Jr. Berchuck A, et al. Among authors: boyer cm. Cancer Res. 1989 Apr 15;49(8):2091-5. Cancer Res. 1989. PMID: 2702650

2

OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.

Xu FJ, Yu YH, Daly L, DeSombre K, Anselmino L, Hass GM, Berchuck A, Soper JT, Clarke-Pearson DL, Boyer C, et al. Xu FJ, et al. J Clin Oncol. 1993 Aug;11(8):1506-10. doi: 10.1200/JCO.1993.11.8.1506. J Clin Oncol. 1993. PMID: 8336189

3

Fibronectin is an immunosuppressive substance associated with epithelial ovarian cancer.

Olt G, Berchuck A, Soisson AP, Boyer CM, Bast RC Jr. Olt G, et al. Among authors: boyer cm. Cancer. 1992 Oct 15;70(8):2137-42. doi: 10.1002/1097-0142(19921015)70:8<2137::aid-cncr2820700821>3.0.co;2-w. Cancer. 1992. PMID: 1394043

4

Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells.

Jerome KR, Barnd DL, Bendt KM, Boyer CM, Taylor-Papadimitriou J, McKenzie IF, Bast RC Jr, Finn OJ. Jerome KR, et al. Among authors: boyer cm. Cancer Res. 1991 Jun 1;51(11):2908-16. Cancer Res. 1991. PMID: 1709586

5

Heterogeneity of antigen expression in advanced epithelial ovarian cancer.

Berchuck A, Olt GJ, Soisson AP, Kamel A, Soper JT, Boyer CM, Clarke-Pearson DL, Leslie DS, Bast RC Jr. Berchuck A, et al. Among authors: boyer cm. Am J Obstet Gynecol. 1990 Apr;162(4):883-8. doi: 10.1016/0002-9378(90)91288-n. Am J Obstet Gynecol. 1990. PMID: 2327461

6

Heterogeneity of antigen expression in benign and malignant breast and ovarian epithelial cells.

Boyer CM, Borowitz MJ, McCarty KS Jr, Kinney RB, Everitt L, Dawson DV, Ring D, Bast RC Jr. Boyer CM, et al. Int J Cancer. 1989 Jan 15;43(1):55-60. doi: 10.1002/ijc.2910430113. Int J Cancer. 1989. PMID: 2463226

7

Differential induction by interferons of major histocompatibility complex-encoded and non-major histocompatibility complex-encoded antigens in human breast and ovarian carcinoma cell lines.

Boyer CM, Dawson DV, Neal SE, Winchell LF, Leslie DS, Ring D, Bast RC Jr. Boyer CM, et al. Cancer Res. 1989 Jun 1;49(11):2928-34. Cancer Res. 1989. PMID: 2497969

8

Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.

Wu S, Boyer CM, Whitaker RS, Berchuck A, Wiener JR, Weinberg JB, Bast RC Jr. Wu S, et al. Among authors: boyer cm. Cancer Res. 1993 Apr 15;53(8):1939-44. Cancer Res. 1993. PMID: 8385577

9

Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2.

Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC Jr. Maier LA, et al. Among authors: boyer cm. Cancer Res. 1991 Oct 1;51(19):5361-9. Cancer Res. 1991. PMID: 1680547

10

The role of peptide growth factors in epithelial ovarian cancer.

Berchuck A, Olt GJ, Everitt L, Soisson AP, Bast RC Jr, Boyer CM. Berchuck A, et al. Among authors: boyer cm. Obstet Gynecol. 1990 Feb;75(2):255-62. Obstet Gynecol. 1990. PMID: 2300354

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters